Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling.
Zak, M., Hanan, E.J., Lupardus, P., Brown, D.G., Robinson, C., Siu, M., Lyssikatos, J.P., Romero, F.A., Zhao, G., Kellar, T., Mendonca, R., Ray, N.C., Goodacre, S.C., Crackett, P.H., McLean, N., Hurley, C.A., Yuen, P.W., Cheng, Y.X., Liu, X., Liimatta, M., Kohli, P.B., Nonomiya, J., Salmon, G., Buckley, G., Lloyd, J., Gibbons, P., Ghilardi, N., Kenny, J.R., Johnson, A.
Bioorg.Med.Chem.Lett.
